Global Generic Medicine Market Size, Status and Forecast 2020-2026

Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Generic Medicine Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Generic Medicine Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Simple Generic Drugs
  • 1.4.3 Super Generic Drugs
  • 1.4.4 Biosimilars
  • 1.4.5 By Application:
  • 1.4.6 CNS
  • 1.4.7 Cardiovascular
  • 1.4.8 Respiratory
  • 1.4.9 Rheumatology
  • 1.4.10 Diabetes
  • 1.4.11 Oncology
• 1.5 Market by Application
  • 1.5.1 Global Generic Medicine Market Share by Application: 2020 VS 2026
  • 1.5.2 CNS
  • 1.5.3 Cardiovascular
  • 1.5.4 Respiratory
  • 1.5.5 Rheumatology
  • 1.5.6 Diabetes
  • 1.5.7 Oncology
  • 1.5.8 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends by Regions

• 2.1 Generic Medicine Market Perspective (2015-2026)
• 2.2 Generic Medicine Growth Trends by Regions
  • 2.2.1 Generic Medicine Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Generic Medicine Historic Market Share by Regions (2015-2020)
  • 2.2.3 Generic Medicine Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Generic Medicine Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Generic Medicine Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Generic Medicine Players by Market Size
  • 3.1.1 Global Top Generic Medicine Players by Revenue (2015-2020)
  • 3.1.2 Global Generic Medicine Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Generic Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Generic Medicine Market Concentration Ratio
  • 3.2.1 Global Generic Medicine Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Generic Medicine Revenue in 2019
• 3.3 Generic Medicine Key Players Head office and Area Served
• 3.4 Key Players Generic Medicine Product Solution and Service
• 3.5 Date of Enter into Generic Medicine Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Generic Medicine Historic Market Size by Type (2015-2020)
• 4.2 Global Generic Medicine Forecasted Market Size by Type (2021-2026)

5 Generic Medicine Breakdown Data by Application (2015-2026)

• 5.1 Global Generic Medicine Market Size by Application (2015-2020)
• 5.2 Global Generic Medicine Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Generic Medicine Market Size (2015-2020)
• 6.2 Generic Medicine Key Players in North America (2019-2020)
• 6.3 North America Generic Medicine Market Size by Type (2015-2020)
• 6.4 North America Generic Medicine Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Generic Medicine Market Size (2015-2020)
• 7.2 Generic Medicine Key Players in Europe (2019-2020)
• 7.3 Europe Generic Medicine Market Size by Type (2015-2020)
• 7.4 Europe Generic Medicine Market Size by Application (2015-2020)

8 China

• 8.1 China Generic Medicine Market Size (2015-2020)
• 8.2 Generic Medicine Key Players in China (2019-2020)
• 8.3 China Generic Medicine Market Size by Type (2015-2020)
• 8.4 China Generic Medicine Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Generic Medicine Market Size (2015-2020)
• 9.2 Generic Medicine Key Players in Japan (2019-2020)
• 9.3 Japan Generic Medicine Market Size by Type (2015-2020)
• 9.4 Japan Generic Medicine Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Generic Medicine Market Size (2015-2020)
• 10.2 Generic Medicine Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Generic Medicine Market Size by Type (2015-2020)
• 10.4 Southeast Asia Generic Medicine Market Size by Application (2015-2020)

11 India

• 11.1 India Generic Medicine Market Size (2015-2020)
• 11.2 Generic Medicine Key Players in India (2019-2020)
• 11.3 India Generic Medicine Market Size by Type (2015-2020)
• 11.4 India Generic Medicine Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Generic Medicine Market Size (2015-2020)
• 12.2 Generic Medicine Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Generic Medicine Market Size by Type (2015-2020)
• 12.4 Central & South America Generic Medicine Market Size by Application (2015-2020)

13Key Players Profiles

• 13.1 Teva
  • 13.1.1 Teva Company Details
  • 13.1.2 Teva Business Overview and Its Total Revenue
  • 13.1.3 Teva Generic Medicine Introduction
  • 13.1.4 Teva Revenue in Generic Medicine Business (2015-2020))
  • 13.1.5 Teva Recent Development
• 13.2 Novartis - Sandoz
  • 13.2.1 Novartis - Sandoz Company Details
  • 13.2.2 Novartis - Sandoz Business Overview and Its Total Revenue
  • 13.2.3 Novartis - Sandoz Generic Medicine Introduction
  • 13.2.4 Novartis - Sandoz Revenue in Generic Medicine Business (2015-2020)
  • 13.2.5 Novartis - Sandoz Recent Development
• 13.3 Mylan
  • 13.3.1 Mylan Company Details
  • 13.3.2 Mylan Business Overview and Its Total Revenue
  • 13.3.3 Mylan Generic Medicine Introduction
  • 13.3.4 Mylan Revenue in Generic Medicine Business (2015-2020)
  • 13.3.5 Mylan Recent Development
• 13.4 Sun Pharmaceutical
  • 13.4.1 Sun Pharmaceutical Company Details
  • 13.4.2 Sun Pharmaceutical Business Overview and Its Total Revenue
  • 13.4.3 Sun Pharmaceutical Generic Medicine Introduction
  • 13.4.4 Sun Pharmaceutical Revenue in Generic Medicine Business (2015-2020)
  • 13.4.5 Sun Pharmaceutical Recent Development
• 13.5 Aspen
  • 13.5.1 Aspen Company Details
  • 13.5.2 Aspen Business Overview and Its Total Revenue
  • 13.5.3 Aspen Generic Medicine Introduction
  • 13.5.4 Aspen Revenue in Generic Medicine Business (2015-2020)
  • 13.5.5 Aspen Recent Development
• 13.6 Fresenius Kabi
  • 13.6.1 Fresenius Kabi Company Details
  • 13.6.2 Fresenius Kabi Business Overview and Its Total Revenue
  • 13.6.3 Fresenius Kabi Generic Medicine Introduction
  • 13.6.4 Fresenius Kabi Revenue in Generic Medicine Business (2015-2020)
  • 13.6.5 Fresenius Kabi Recent Development
• 13.7 Pfizer (Hospira)
  • 13.7.1 Pfizer (Hospira) Company Details
  • 13.7.2 Pfizer (Hospira) Business Overview and Its Total Revenue
  • 13.7.3 Pfizer (Hospira) Generic Medicine Introduction
  • 13.7.4 Pfizer (Hospira) Revenue in Generic Medicine Business (2015-2020)
  • 13.7.5 Pfizer (Hospira) Recent Development
• 13.8 Sanofi
  • 13.8.1 Sanofi Company Details
  • 13.8.2 Sanofi Business Overview and Its Total Revenue
  • 13.8.3 Sanofi Generic Medicine Introduction
  • 13.8.4 Sanofi Revenue in Generic Medicine Business (2015-2020)
  • 13.8.5 Sanofi Recent Development
• 13.9 Aurobindo
  • 13.9.1 Aurobindo Company Details
  • 13.9.2 Aurobindo Business Overview and Its Total Revenue
  • 13.9.3 Aurobindo Generic Medicine Introduction
  • 13.9.4 Aurobindo Revenue in Generic Medicine Business (2015-2020)
  • 13.9.5 Aurobindo Recent Development
• 13.10 Lupin
  • 13.10.1 Lupin Company Details
  • 13.10.2 Lupin Business Overview and Its Total Revenue
  • 13.10.3 Lupin Generic Medicine Introduction
  • 13.10.4 Lupin Revenue in Generic Medicine Business (2015-2020)
  • 13.10.5 Lupin Recent Development
• 13.11 Dr. Reddy's
  • 10.11.1 Dr. Reddy's Company Details
  • 10.11.2 Dr. Reddy's Business Overview and Its Total Revenue
  • 10.11.3 Dr. Reddy's Generic Medicine Introduction
  • 10.11.4 Dr. Reddy's Revenue in Generic Medicine Business (2015-2020)
  • 10.11.5 Dr. Reddy's Recent Development
• 13.12 Apotex
  • 10.12.1 Apotex Company Details
  • 10.12.2 Apotex Business Overview and Its Total Revenue
  • 10.12.3 Apotex Generic Medicine Introduction
  • 10.12.4 Apotex Revenue in Generic Medicine Business (2015-2020)
  • 10.12.5 Apotex Recent Development
• 13.13 Cipla
  • 10.13.1 Cipla Company Details
  • 10.13.2 Cipla Business Overview and Its Total Revenue
  • 10.13.3 Cipla Generic Medicine Introduction
  • 10.13.4 Cipla Revenue in Generic Medicine Business (2015-2020)
  • 10.13.5 Cipla Recent Development
• 13.14 ENDO (Par Pharmaceutical)
  • 10.14.1 ENDO (Par Pharmaceutical) Company Details
  • 10.14.2 ENDO (Par Pharmaceutical) Business Overview and Its Total Revenue
  • 10.14.3 ENDO (Par Pharmaceutical) Generic Medicine Introduction
  • 10.14.4 ENDO (Par Pharmaceutical) Revenue in Generic Medicine Business (2015-2020)
  • 10.14.5 ENDO (Par Pharmaceutical) Recent Development
• 13.15 Stada Arzneimittel
  • 10.15.1 Stada Arzneimittel Company Details
  • 10.15.2 Stada Arzneimittel Business Overview and Its Total Revenue
  • 10.15.3 Stada Arzneimittel Generic Medicine Introduction
  • 10.15.4 Stada Arzneimittel Revenue in Generic Medicine Business (2015-2020)
  • 10.15.5 Stada Arzneimittel Recent Development
• 13.16 Krka Group
  • 10.16.1 Krka Group Company Details
  • 10.16.2 Krka Group Business Overview and Its Total Revenue
  • 10.16.3 Krka Group Generic Medicine Introduction
  • 10.16.4 Krka Group Revenue in Generic Medicine Business (2015-2020)
  • 10.16.5 Krka Group Recent Development
• 13.17 Nichi-Iko Pharmaceutical
  • 10.17.1 Nichi-Iko Pharmaceutical Company Details
  • 10.17.2 Nichi-Iko Pharmaceutical Business Overview and Its Total Revenue
  • 10.17.3 Nichi-Iko Pharmaceutical Generic Medicine Introduction
  • 10.17.4 Nichi-Iko Pharmaceutical Revenue in Generic Medicine Business (2015-2020)
  • 10.17.5 Nichi-Iko Pharmaceutical Recent Development
• 13.18 Valeant
  • 10.18.1 Valeant Company Details
  • 10.18.2 Valeant Business Overview and Its Total Revenue
  • 10.18.3 Valeant Generic Medicine Introduction
  • 10.18.4 Valeant Revenue in Generic Medicine Business (2015-2020)
  • 10.18.5 Valeant Recent Development
• 13.19 Zydus Cadila
  • 10.19.1 Zydus Cadila Company Details
  • 10.19.2 Zydus Cadila Business Overview and Its Total Revenue
  • 10.19.3 Zydus Cadila Generic Medicine Introduction
  • 10.19.4 Zydus Cadila Revenue in Generic Medicine Business (2015-2020)
  • 10.19.5 Zydus Cadila Recent Development
• 13.20 Hikma
  • 10.20.1 Hikma Company Details
  • 10.20.2 Hikma Business Overview and Its Total Revenue
  • 10.20.3 Hikma Generic Medicine Introduction
  • 10.20.4 Hikma Revenue in Generic Medicine Business (2015-2020)
  • 10.20.5 Hikma Recent Development

14Analyst's Viewpoints/Conclusions

15Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer